source
- Treasury to tighten scrutiny of China biotech acquisitions under upcoming rulesTreasury Secretary Scott Bessent announced on Sept 9 2026 that the Treasury Department will issue new guidance that makes it harder for U.S. pharma companies to complete biotech deals in China. Th…
- CSL appoints former ViiV and GSK veteran Deborah Waterhouse as new CEOCSL announced that Deborah Waterhouse will become its chief executive. The appointment follows her departure from GSK, where she spent three decades. Waterhouse most recently led ViiV Healthcare,…